Recital 5, Regulation (EU) 2024/996

In forcesince 3 Apr 2024

The SCCS concluded in its opinion of 27 May 2015 on Alpha-Arbutin [SCCS (Scientific Committee on Consumer Safety), Opinion on α-arbutin, 27 May 2015, SCCS/1552/15.] and in its opinion of 25 March 2015 on Arbutin [SCCS (Scientific Committee on Consumer Safety), Opinion on β-arbutin, SCCS/1550/15, 25 March 2015.] that both substances, when used in limited concentrations, were safe for consumers in cosmetic products. However, it stressed that the potential combined use of those substances and other hydroquinone releasing substances in cosmetic products was not evaluated, and that it could be of concern. On 31 January 2023, the SCCS adopted an opinion on the safety of Alpha-Arbutin and Arbutin in cosmetic products [SCCS (Scientific Committee on Consumer Safety), Opinion on the safety of alpha- (CAS No 84380-018, EC No 617-561-8) and beta-arbutin (CAS No 497-76-7, EC No 207-8503) in cosmetic products, preliminary version of 15-16 March 2022, final version of 31 January 2023, SCCS/1642/22.] confirming its previous conclusion that Alpha-Arbutin used in face creams up to a maximum concentration of 2 % and in body lotions up to a concentration of 0,5 % is safe and that Arbutin used in face creams up to a maximum concentration of 7 % is safe. The SCCS also concluded that the aggregate exposure of Alpha-Arbutin with Arbutin are considered safe for consumers. The SCCS also stressed that the presence of Hydroquinone (CAS No 123-31-9) should remain as low as possible in formulations containing Alpha-Arbutin and Arbutin and should not be higher than the unavoidable trace levels.